Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
about
Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfallsHypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapyTargeting von Willebrand factor and platelet glycoprotein Ib receptor.Effects of in vitro adult platelet transfusions on neonatal hemostasisClinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy.Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery.Von Willebrand factor and oxidative stress parameters in acute coronary syndromesPlatelet hyperreactivity: predictive and intrinsic propertiesHuman genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stressMorphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers.A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes.Platelet function and inhibition in ischemic heart disease.Influence of platelet reactivity on clinical outcome of patients with stable coronary artery disease.Platelet function tests for the monitoring of P2Y12 inhibitors.The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men.Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.Vascular and platelet responses to aspirin in patients with coronary artery disease.Clinical significance of baseline platelet reactivity in patients with acute coronary syndrome.Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.Monitoring aspirin therapy with the Platelet Function Analyzer-100.Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.Testing aspirin resistance using the Platelet Function Analyzer-100: some methodological caveats and considerations.TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study.Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans.Clinical Significance of Laboratory-determined Aspirin Poor Responsiveness After Primary Percutaneous Coronary Intervention.Effects of prasugrel on platelet inhibition during systemic endotoxaemia: a randomized controlled trial.Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis
P2860
Q26775125-B2100D3E-E5D4-46C6-9097-47C00BEE295BQ28221437-7CB288C4-A058-46B2-B3F0-9F865E18564CQ33392975-6B7E4352-195A-45D9-B14A-3D692A6A88CEQ33394140-64624C7D-652B-454A-8706-50EA0952AB35Q34288732-B3B6A3A7-3F9E-426B-9684-0174CB3305E6Q34952522-E0D6A031-182A-4E42-8B01-91A826368A44Q35193909-77AC1FB0-5EC3-4D8A-BBA1-C8B63AFBED29Q36002765-FFF96E96-8F79-4097-A8A7-085B7F3AF3A1Q36449448-D868E6C1-417E-4729-81E5-3BF247CAA9E1Q36723867-9D379096-AAB0-4447-A242-C5D71B0AE34DQ37550156-3624D227-0D54-4F27-9A17-BC6E0FFA36E6Q38007894-1451C5AD-2F46-4D96-BBC9-E581A30F74FCQ38071262-F427040A-9C64-452D-9020-9DF8D511DFE1Q38089082-E675DF53-D916-4967-83DD-939BCCA34B98Q38351931-B03E3BFC-7C90-49C9-A0CE-29D0360B740CQ38958862-557AE350-80DE-4F79-9303-7964BA732C72Q42167779-15A91C14-FCDA-4D34-A2A3-B800FD87AED8Q42667008-F0DE257C-037F-4881-AA4D-E2FE0CADB03CQ43970520-111EC858-8722-434E-BF59-A171ABD5311FQ45255393-4F4BCE75-3765-4C7C-A497-3F980204A004Q46367587-CC240343-4E01-45C8-B737-88CED5A5BBE9Q46465847-B32DF277-C23A-4E03-89A3-B0806712E626Q46790430-F612A904-E81E-4251-AD00-186E629E7C9AQ46884137-4F9D85ED-F81C-41D3-A276-671F3A73D7D2Q47993062-36C8A475-7C08-4103-B891-7B780CD8F5BDQ51312219-8512D7E2-2B60-4DAB-BFB9-0E46A8A59A6FQ53932544-B43BC15B-D6D6-4518-A142-737268E4119DQ54217048-CEB4060D-5DE0-4F71-B405-00896BE02C36Q54335457-F5101E82-6B45-4AF2-A28E-3F018BFAA5C3Q57734957-52EBA9C0-2695-4776-BEA1-10DF0978E91B
P2860
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
description
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: December 2006)
@en
vedecký článok (publikovaný 2006-12)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd in 2006-12)
@nl
наукова стаття, опублікована в грудні 2006
@uk
مقالة علمية (نشرت في ديسمبر 2006)
@ar
name
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@ast
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@en
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@nl
type
label
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@ast
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@en
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@nl
prefLabel
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@ast
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@en
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@nl
P2093
P1476
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
@en
P2093
P304
P356
10.1111/J.1538-7836.2006.02239.X
P407
P577
2006-09-26T00:00:00Z